Skip to main content
NCBI home page
Heart logoLink to Heart
. 1996 Jan;75(1):94–97. doi: 10.1136/hrt.75.1.94

Restrictive and hypertrophic cardiomyopathies in Noonan syndrome: the overlap syndromes.

P T Wilmshurst 1, D Katritsis 1
PMCID: PMC484232  PMID: 8624883

Abstract

A woman with Noonan syndrome had clinical and haemodynamic features of restrictive cardiomyopathy. There was no ventricular hypertrophy on echocardiography but myocardial biopsies showed myocyte hypertrophy without pathological disarray. This case illustrates the overlap of the cardiac phenotypes of Noonan syndrome, restrictive cardiomyopathy, and hypertrophic cardiomyopathy.

Full text

PDF
94

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Altman D. I., Murray J., Milner S., Dansky R., Levin S. E. Asymmetric septal hypertrophy and hypothyroidism in children. Br Heart J. 1985 Nov;54(5):533–538. doi: 10.1136/hrt.54.5.533. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bell R., Barber P. V., Bray C. L., Beton D. C. Incidence of thyroid disease in cases of hypertrophic cardiomyopathy. Br Heart J. 1978 Nov;40(11):1306–1309. doi: 10.1136/hrt.40.11.1306. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Brunner H. G., Jansen G., Nillesen W., Nelen M. R., de Die C. E., Höweler C. J., van Oost B. A., Wieringa B., Ropers H. H., Smeets H. J. Brief report: reverse mutation in myotonic dystrophy. N Engl J Med. 1993 Feb 18;328(7):476–480. doi: 10.1056/NEJM199302183280705. [DOI] [PubMed] [Google Scholar]
  4. Carrier L., Hengstenberg C., Beckmann J. S., Guicheney P., Dufour C., Bercovici J., Dausse E., Berebbi-Bertrand I., Wisnewsky C., Pulvenis D. Mapping of a novel gene for familial hypertrophic cardiomyopathy to chromosome 11. Nat Genet. 1993 Jul;4(3):311–313. doi: 10.1038/ng0793-311. [DOI] [PubMed] [Google Scholar]
  5. Cooke R. A., Chambers J. B., Curry P. V. Noonan's cardiomyopathy: a non-hypertrophic variant. Br Heart J. 1994 Jun;71(6):561–565. doi: 10.1136/hrt.71.6.561. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Dillmann W. H. Biochemical basis of thyroid hormone action in the heart. Am J Med. 1990 Jun;88(6):626–630. doi: 10.1016/0002-9343(90)90530-q. [DOI] [PubMed] [Google Scholar]
  7. Fananapazir L., Epstein N. D. Genotype-phenotype correlations in hypertrophic cardiomyopathy. Insights provided by comparisons of kindreds with distinct and identical beta-myosin heavy chain gene mutations. Circulation. 1994 Jan;89(1):22–32. doi: 10.1161/01.cir.89.1.22. [DOI] [PubMed] [Google Scholar]
  8. Fitzpatrick A. P., Shapiro L. M., Rickards A. F., Poole-Wilson P. A. Familial restrictive cardiomyopathy with atrioventricular block and skeletal myopathy. Br Heart J. 1990 Feb;63(2):114–118. doi: 10.1136/hrt.63.2.114. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Flintoff W. F., Bahuau M., Lyonnet S., Gilgenkrantz S., Lacombe D., Marçon F., Levilliers J., Kachaner J., Munnich A., Le Merrer M. No evidence for linkage to the type 1 or type 2 neurofibromatosis loci in Noonan syndrome families. Am J Med Genet. 1993 Jul 1;46(6):700–705. doi: 10.1002/ajmg.1320460621. [DOI] [PubMed] [Google Scholar]
  10. Hall J. G. Genomic imprinting: review and relevance to human diseases. Am J Hum Genet. 1990 May;46(5):857–873. [PMC free article] [PubMed] [Google Scholar]
  11. Hirota Y., Shimizu G., Kita Y., Nakayama Y., Suwa M., Kawamura K., Nagata S., Sawayama T., Izumi T., Nakano T. Spectrum of restrictive cardiomyopathy: report of the national survey in Japan. Am Heart J. 1990 Jul;120(1):188–194. doi: 10.1016/0002-8703(90)90177-y. [DOI] [PubMed] [Google Scholar]
  12. Jamieson C. R., van der Burgt I., Brady A. F., van Reen M., Elsawi M. M., Hol F., Jeffery S., Patton M. A., Mariman E. Mapping a gene for Noonan syndrome to the long arm of chromosome 12. Nat Genet. 1994 Dec;8(4):357–360. doi: 10.1038/ng1294-357. [DOI] [PubMed] [Google Scholar]
  13. Katritsis D., Wilmshurst P. T., Wendon J. A., Davies M. J., Webb-Peploe M. M. Primary restrictive cardiomyopathy: clinical and pathologic characteristics. J Am Coll Cardiol. 1991 Nov 1;18(5):1230–1235. doi: 10.1016/0735-1097(91)90540-p. [DOI] [PubMed] [Google Scholar]
  14. Komuro I., Yazaki Y. Molecular mechanism of cardiac hypertrophy and failure. Clin Sci (Lond) 1994 Aug;87(2):115–116. doi: 10.1042/cs0870115. [DOI] [PubMed] [Google Scholar]
  15. Maron B. J., Kragel A. H., Roberts W. C. Sudden death in hypertrophic cardiomyopathy with normal left ventricular mass. Br Heart J. 1990 May;63(5):308–310. doi: 10.1136/hrt.63.5.308. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. McKenna W. J., Stewart J. T., Nihoyannopoulos P., McGinty F., Davies M. J. Hypertrophic cardiomyopathy without hypertrophy: two families with myocardial disarray in the absence of increased myocardial mass. Br Heart J. 1990 May;63(5):287–290. doi: 10.1136/hrt.63.5.287. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Mendez H. M., Opitz J. M. Noonan syndrome: a review. Am J Med Genet. 1985 Jul;21(3):493–506. doi: 10.1002/ajmg.1320210312. [DOI] [PubMed] [Google Scholar]
  18. Morkin E. Regulation of myosin heavy chain genes in the heart. Circulation. 1993 May;87(5):1451–1460. doi: 10.1161/01.cir.87.5.1451. [DOI] [PubMed] [Google Scholar]
  19. Obayashi T., Hattori K., Sugiyama S., Tanaka M., Tanaka T., Itoyama S., Deguchi H., Kawamura K., Koga Y., Toshima H. Point mutations in mitochondrial DNA in patients with hypertrophic cardiomyopathy. Am Heart J. 1992 Nov;124(5):1263–1269. doi: 10.1016/0002-8703(92)90410-w. [DOI] [PubMed] [Google Scholar]
  20. Pearcé P. C., Hawkey C., Symons C., Olsen E. G. Role of calcium in the induction of cardiac hypertrophy and myofibrillar disarray. Experimental studies of a possible cause of hypertrophic cardiomyopathy. Br Heart J. 1985 Oct;54(4):420–427. doi: 10.1136/hrt.54.4.420. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Rampazzo A., Nava A., Danieli G. A., Buja G., Daliento L., Fasoli G., Scognamiglio R., Corrado D., Thiene G. The gene for arrhythmogenic right ventricular cardiomyopathy maps to chromosome 14q23-q24. Hum Mol Genet. 1994 Jun;3(6):959–962. doi: 10.1093/hmg/3.6.959. [DOI] [PubMed] [Google Scholar]
  22. Rohrer D. K., Hartong R., Dillmann W. H. Influence of thyroid hormone and retinoic acid on slow sarcoplasmic reticulum Ca2+ ATPase and myosin heavy chain alpha gene expression in cardiac myocytes. Delineation of cis-active DNA elements that confer responsiveness to thyroid hormone but not to retinoic acid. J Biol Chem. 1991 May 5;266(13):8638–8646. [PubMed] [Google Scholar]
  23. Santos A. D., Miller R. P., Mathew P. K., Wallace W. A., Cave W. T., Jr, Hinojosa L. Echocardiographic characterization of the reversible cardiomyopathy of hypothyroidism. Am J Med. 1980 May;68(5):675–682. doi: 10.1016/0002-9343(80)90253-3. [DOI] [PubMed] [Google Scholar]
  24. Sharland M., Burch M., McKenna W. M., Paton M. A. A clinical study of Noonan syndrome. Arch Dis Child. 1992 Feb;67(2):178–183. doi: 10.1136/adc.67.2.178. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Shelbourne P., Davies J., Buxton J., Anvret M., Blennow E., Bonduelle M., Schmedding E., Glass I., Lindenbaum R., Lane R. Direct diagnosis of myotonic dystrophy with a disease-specific DNA marker. N Engl J Med. 1993 Feb 18;328(7):471–475. doi: 10.1056/NEJM199302183280704. [DOI] [PubMed] [Google Scholar]
  26. Smith E. R., Heffernan L. P., Sangalang V. E., Vaughan L. M., Flemington C. S. Voluntary muscle involvement in hypertrophic cardiomyopathy. A study of eleven patients. Ann Intern Med. 1976 Nov;85(5):566–572. doi: 10.7326/0003-4819-85-5-566. [DOI] [PubMed] [Google Scholar]
  27. Terrett J. A., Newbury-Ecob R., Cross G. S., Fenton I., Raeburn J. A., Young I. D., Brook J. D. Holt-Oram syndrome is a genetically heterogeneous disease with one locus mapping to human chromosome 12q. Nat Genet. 1994 Apr;6(4):401–404. doi: 10.1038/ng0494-401. [DOI] [PubMed] [Google Scholar]
  28. Watkins H., McKenna W. J., Thierfelder L., Suk H. J., Anan R., O'Donoghue A., Spirito P., Matsumori A., Moravec C. S., Seidman J. G. Mutations in the genes for cardiac troponin T and alpha-tropomyosin in hypertrophic cardiomyopathy. N Engl J Med. 1995 Apr 20;332(16):1058–1064. doi: 10.1056/NEJM199504203321603. [DOI] [PubMed] [Google Scholar]
  29. Watkins H., Rosenzweig A., Hwang D. S., Levi T., McKenna W., Seidman C. E., Seidman J. G. Characteristics and prognostic implications of myosin missense mutations in familial hypertrophic cardiomyopathy. N Engl J Med. 1992 Apr 23;326(17):1108–1114. doi: 10.1056/NEJM199204233261703. [DOI] [PubMed] [Google Scholar]
  30. Wilmshurst P., Da Costa P. Probable right ventricular dysplasia and patent foramen ovale presenting with cyanosis and clubbing in a patient with characteristics of Noonan syndrome. Br Heart J. 1995 Oct;74(4):471–475. doi: 10.1136/hrt.74.4.471. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Heart are provided here courtesy of BMJ Publishing Group

RESOURCES